Dipyrone and blood dyscrasia revisited: "non-evidence based medicine"

Editorial

Isabela M Benseñor. Sao Paulo Med J. 2005.

. 2005 May 2;123(3):99-100.

doi: 10.1590/s1516-31802005000300001. Epub 2005 Jul 8.

No abstract available

Comment on

Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study.
Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, Okano IR, Falcão RP, Pita MT, Loggetto SR, Rosenfeld LG, Lorand-Metze IG. Hamerschlak N, et al. Sao Paulo Med J. 2005 May 2;123(3):101-4. doi: 10.1590/s1516-31802005000300002. Epub 2005 Jul 8. Sao Paulo Med J. 2005. PMID: 16021270 Free PMC article.

1. Hamerschlak N, Maluf E, Paquini R, et al. LATIN study – Incidence of aplastic anemia and agranulocytosis in Latin America. Sao Paulo Med J. 2005;123(3):101–104. - PMC - PubMed
1. Shapiro S, Issaragrisil S, Kaufman DW, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg. 1999;60(4):573–577. - PubMed
1. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159(4):369–374. - PubMed
1. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA. 1986;256(13):1749–1757. - PubMed
1. Dorr VJ, Cook J. Agranulocytosis and near fatal sepsis due to "Mexican aspirin" (dipyrone) South Med J. 1996;89(6):612–614. - PubMed